XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 10 - Share-based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
           

Weighted Average

         
   

Options on

           

Remaining

   

Aggregate

 
   

Common

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term

   

Value

 

Outstanding January 1, 2022

    3,935,883     $ 5.24       4.79          

Granted

    2,734,639     $ 2.85                  

Exercised

    (55,500 )   $ 1.50                  

Forfeited, cancelled, expired

    (978,709 )   $ 5.48                  

Outstanding September 30, 2022

    5,636,313     $ 3.74       6.01     $ 232,778  

Exercisable September 30, 2022

    2,507,744     $ 4.47       2.14     $ 232,778  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

For the Nine months

 
   

Ended September 30,

 
   

2022

   

2021

 

Expected stock price volatility

   

49

%

   

50

%

Risk-free interest rate

   

1.17

%

   

0.90

%

Expected dividend yield

   

0

%

   

0

%

Expected life of options - years

   

3.46

     

5.74

 

Weighted-average fair value of options granted

  $

1.25

    $

2.57

 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
           

Weighted Average

   

Weighted Average

 
   

Service-Based

   

Grant Date

   

Vesting

 
   

RSU's

   

Fair Value

   

Period (Years)

 

Unvested at January 1, 2022

    269,303     $ 6.47          

Granted - service based

    753,817     $ 2.57          

Vested

    (218,133 )   $ 4.93          

Forfeited and cancelled

    (60,023 )   $ 6.57          

Unvested at September 30, 2022

    744,964     $ 2.97       2.32  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
   

Three Months Ended

September 30,

   

Nine months Ended

September 30,

 
   

2022

   

2021

   

2022

   

2021

 

Selling, general and administrative

  $ 700     $ 1,093     $ 2,180     $ 3,722  

Research and development

    172       210       448       588  

Total share-based expense

  $ 872     $ 1,303     $ 2,628     $ 4,310